Trademarkia Logo

United Kingdom

£
Trademark Search
SCRIBE

View On IPO.GOV.UK

Registered

on 7 May 2019

Last Applicant/ Owned by

Scribe Therapeutics Inc.

164 Vicente Road Berkeley CA 94705

, ,

Serial Number

UK00801483276 filed on 7th May 2019

Registration Number

UK00801483276 registered on
24th Jan 2020

Correspondent Information

Cooley (UK) LLP

22 Bishopsgate

London,

EC2N 4BQ

SCRIBE

pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases i Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical and biological preparations based on genetic engineering and gene therapy for use in diagnosis, prevention, and treatment of diseases in human therapeutics; gene therapy products, namely, biological preparations based on engineered cells for medical use in immuno oncology, degenerative disorders, traumatic injury, enzyme replacement therapy, and immunology; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders, including neurological disorders, Huntington's disease, amyotrophic lateral sclerosis (ALS), front temporal dementia, pain, Alzheimer's, Parkinson's, ataxia, autism, epilepsy, pain, and also including cardiovascular, peripheral nervous system, cancer, endocrine, gastrointestinal, renal, genetic immunological, hepatic, infectious, inflammatory, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, respiratory, urogenital, urological, hematologic and viral or bacterial diseases and disorders.

Class [42]
Computer & Software Services & Scientific Services

Scientific and medical research in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering research and development of pharmaceuticals, biological preparations, diagnostic and therapeutic products and services; design and development of engineered cells for use in scientific research and drug discovery and development; providing medical research and scientific research information in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy, and genetic engineering; molecular diagnostic services for medical research purposes.

Class [44]
Medical, Beauty & Agricultural Services

Molecular diagnostic services for medical purposes; medical diagnostic testing services in the field of human disease and human medical conditions.

Mark Details

Serial Number

UK00801483276

Mark Type

Word

Kind of mark

Individual